According to Globant's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 51.4091. At the end of 2022 the company had a P/E ratio of 47.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 47.2 | -64.96% |
2021 | 135 | -12.65% |
2020 | 154 | 113.93% |
2019 | 72.1 | 84.46% |
2018 | 39.1 | -24.24% |
2017 | 51.6 | 65.62% |
2016 | 31.2 | -23.55% |
2015 | 40.8 | 98.29% |
2014 | 20.6 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Workiva
WK | -31.7 | -161.60% | ๐บ๐ธ USA |
SPS Commerce
SPSC | 104 | 102.08% | ๐บ๐ธ USA |
Qualys QLYS | 52.9 | 2.87% | ๐บ๐ธ USA |
Castlight Health
CSLT | N/A | N/A | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.